22
Jun
2015
The Long Slog For Better Drug Safety Monitoring Is Paying Off
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account. 
Share:
19
Jun
2015
Like the TR? Tell a Friend to Subscribe, and Enter to Win a T-Shirt
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
19
Jun
2015
Who’s Exploring DNA ‘Dark Matter’ for Drug Discovery?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
15
Jun
2015
It’s Time to Re-Think Some Assumptions About Cancer R&D
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
11
Jun
2015
NEA, Polaris Bet $22M on Startup, Xtuit, to Break Down Tumor Microenvironment
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
8
Jun
2015
Bristol-Myers Should Drop the Bully Act. Non-Competes Are Bad for Biotech
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
5
Jun
2015
Cancer is Hot, Diabetes is Not: Watch for Drug Safety and Cost Debates at ADA
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
1
Jun
2015
Big Pharma Talent Is Flocking to Biotech Startups. Nobody’s Saying ‘Are You Nuts?’
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
29
May
2015
Cancer Immunotherapy’s Amazing Four-Year Run: A Timeline of Events
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
26
May
2015
Long-Term Relationships May Not Count in Many Businesses, But They Do in Biotech
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
22
May
2015
The Genentech Alumni: Where Are They Now?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
21
May
2015
Why a Pfizer R&D Exec Joined Synlogic to Make ‘Therapeutic Synthetic Life’
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
18
May
2015
Zigging Away From the Herd: Lilly’s Road-Less-Traveled R&D Strategy
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
15
May
2015
More than Moderna: Who’s Who in mRNA Therapeutics?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
11
May
2015
How Do VCs Divvy Up Their Pay?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
7
May
2015
Gates Foundation VC Portfolio: Where is the Global Health Investment Going?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
4
May
2015
What’s Real, and What’s Not Yet, in Digital Health?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
29
Apr
2015
Q&A With Illumina CEO Jay Flatley on Where Genomics Is Growing
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
27
Apr
2015
It’s Time to Re-Think How We Train and Develop Biomedical Scientists
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
23
Apr
2015
See the Photos: Timmerman Report East Coast Launch Party
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share: